BIONANO GENOMICS INC (BNGO)

US09075F3055 - Common Stock

0.2101  +0.01 (+3.8%)

News Image
3 days ago - Bionano Genomics

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

In the largest study to date of bone and soft tissue tumors, OGM detected 100% of the variants found by multiple standard techniques, including...

News Image
a month ago - The Motley Fool

Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript

BNGO earnings call for the period ending September 30, 2024.

News Image
a month ago - Bionano Genomics

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress...

News Image
2 months ago - Bionano Genomics

Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024

Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024...

News Image
2 months ago - Bionano Genomics

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered...

News Image
2 months ago - Bionano Genomics

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

Special Meeting of Stockholders Adjourned Due to Lack of Quorum...

News Image
3 months ago - Bionano Genomics

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended...

News Image
5 months ago - The Motley Fool

Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript

BNGO earnings call for the period ending June 30, 2024.

News Image
5 months ago - InvestorPlace

BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024

BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

News Image
5 months ago - BusinessInsider

BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ:BNGO) just reported results for the second quarter of ...

News Image
5 months ago - Bionano Genomics

Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress

Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress...

News Image
5 months ago - Bionano Genomics

Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting

SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- A sponsored exhibitor session will feature Dr. Phillip Michaels from Harvard Medical School and Brigham and...

News Image
5 months ago - Bionano Genomics

Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference

SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief...

News Image
5 months ago - InvestorPlace

3 Quantum AI Stocks That Could Redefine Computing

Three quantum AI stocks could shape the future of computing, which means current market prices are very cheap.

News Image
6 months ago - Bionano Genomics

Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants...

News Image
6 months ago - Bionano Genomics

Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants...

News Image
6 months ago - Bionano Genomics

Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting

A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia...

News Image
6 months ago - Bionano Genomics

Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

Bionano announces software marketing agreement with Revvity for newborn sequencing research workflow....

News Image
7 months ago - InvestorPlace

3 Sorry Healthcare Stocks to Sell in May While You Still Can

Steer clear of these three companies facing significant challenges. Discover why these are risky healthcare stocks to sell.

News Image
8 months ago - InvestorPlace

The 3 Best Healthcare Stocks to Buy in May 2024

Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now.

News Image
8 months ago - InvestorPlace

BNGO Stock Earnings: Bionano Genomics Beats EPS, Beats Revenue for Q1 2024

BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

News Image
8 months ago - BusinessInsider

BNGO Stock Earnings: Bionano Genomics Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ:BNGO) just reported results for the first quarter of 2...

News Image
8 months ago - The Motley Fool

Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript

BNGO earnings call for the period ending March 31, 2024.

News Image
8 months ago - Bionano Genomics

Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress

Q1 2024 revenue was $8.8 million, which represents an 18% increase over Q1 2023Total installed base of 347 optical genome mapping (OGM) systems as of Q1...

News Image
8 months ago - InvestorPlace

3 Contrarian Investments to Make Now for Massive Upside Potential

A combination of nervous investors and highly aggressive short sellers has made many contrarian investments quite attractive. 

News Image
9 months ago - Bionano Genomics

Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing

Researchers used optical genome mapping in addition to whole genome sequencing in pediatric leukemia samples and identified additional structural...

News Image
9 months ago - Bionano Genomics

Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules...

News Image
9 months ago - Bionano Genomics

Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics

A peer-reviewed study compared optical genome mapping (OGM) to classical cytogenetic techniques used for analysis of solid tumor cancer samples. ...

News Image
10 months ago - Bionano Genomics

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System

Bionano will host a pre-conference scientific session that will include a live product demonstration of the Stratys™ system for high throughput optical...

News Image
10 months ago - The Motley Fool

Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript

BNGO earnings call for the period ending December 31, 2023.

News Image
10 months ago - InvestorPlace

BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023

BNGO stock results show that Bionano Genomics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

News Image
10 months ago - BusinessInsider

BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ:BNGO) just reported results for the fourth quarter of ...

News Image
10 months ago - Bionano Genomics

Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024

Q4 2023 revenue was $10.7 million, which represents a 30% increase over Q4 2022FY 2023 revenue was $36.1 million, which represents a 30% increase over FY...

News Image
10 months ago - Bionano Genomics

Bionano to Present at TD Cowen’s 44th Annual Health Care Conference

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief...